RecruitingNot ApplicableNCT05390424

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot


Sponsor

University Hospital, Rouen

Enrollment

500 participants

Start Date

Dec 2, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a rapid, non-invasive saliva-based test can reliably screen for hepatitis B, hepatitis C, and HIV — making it easier for people who use drugs to get tested, since they may have difficulty accessing traditional blood draw testing at a clinic. **You may be eligible if...** - You are a current or former intravenous or nasal drug user - OR you are currently receiving medication-assisted treatment for opioid dependence (such as methadone or buprenorphine) **You may NOT be eligible if...** - You are already known to have an active viral infection (hepatitis B, hepatitis C, or HIV) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood collection using Dried Blood Spot

Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection


Locations(11)

Caarud Sud Manche

Avranches, France

Csapa Barentin

Barentin, France

Oeuvre Normande Des Meres

Dieppe, France

Csapa Act

Elbeuf, France

Csapa Gisors

Gisors, France

Csapa Nautilia

Le Havre, France

Csapa Pont-Audemer

Pont-Audemer, France

Aides Region Normandie

Rouen, France

Csapa-Caarud La Boussole

Rouen, France

Chu Rouen

Rouen, France

Csapa Caux Et Bray

Yvetot, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05390424


Related Trials